End-stage heart failure in congenitally corrected transposition of the great arteries : a multicentre study
© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology..
BACKGROUND AND AIMS: For patients with congenitally corrected transposition of the great arteries (ccTGA), factors associated with progression to end-stage congestive heart failure (CHF) remain largely unclear.
METHODS: This multicentre, retrospective cohort study included adults with ccTGA seen at a congenital heart disease centre. Clinical data from initial and most recent visits were obtained. The composite primary outcome was mechanical circulatory support, heart transplantation, or death.
RESULTS: From 558 patients (48% female, age at first visit 36 ± 14.2 years, median follow-up 8.7 years), the event rate of the primary outcome was 15.4 per 1000 person-years (11 mechanical circulatory support implantations, 12 transplantations, and 52 deaths). Patients experiencing the primary outcome were older and more likely to have a history of atrial arrhythmia. The primary outcome was highest in those with both moderate/severe right ventricular (RV) dysfunction and tricuspid regurgitation (n = 110, 31 events) and uncommon in those with mild/less RV dysfunction and tricuspid regurgitation (n = 181, 13 events, P < .001). Outcomes were not different based on anatomic complexity and history of tricuspid valve surgery or of subpulmonic obstruction. New CHF admission or ventricular arrhythmia was associated with the primary outcome. Individuals who underwent childhood surgery had more adverse outcomes than age- and sex-matched controls. Multivariable Cox regression analysis identified older age, prior CHF admission, and severe RV dysfunction as independent predictors for the primary outcome.
CONCLUSIONS: Patients with ccTGA have variable deterioration to end-stage heart failure or death over time, commonly between their fifth and sixth decades. Predictors include arrhythmic and CHF events and severe RV dysfunction but not anatomy or need for tricuspid valve surgery.
| Errataetall: |
CommentIn: Eur Heart J. 2023 Sep 7;44(34):3292-3294. - PMID 37592741 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:44 |
|---|---|
| Enthalten in: |
European heart journal - 44(2023), 34 vom: 07. Sept., Seite 3278-3291 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 08.09.2023 Date Revised 07.02.2024 published: Print CommentIn: Eur Heart J. 2023 Sep 7;44(34):3292-3294. - PMID 37592741 Citation Status MEDLINE |
|---|
| doi: |
10.1093/eurheartj/ehad511 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM360916767 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM360916767 | ||
| 003 | DE-627 | ||
| 005 | 20240207232031.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/eurheartj/ehad511 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1283.xml |
| 035 | |a (DE-627)NLM360916767 | ||
| 035 | |a (NLM)37592821 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a van Dissel, Alexandra C |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a End-stage heart failure in congenitally corrected transposition of the great arteries |b a multicentre study |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.09.2023 | ||
| 500 | |a Date Revised 07.02.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentIn: Eur Heart J. 2023 Sep 7;44(34):3292-3294. - PMID 37592741 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. | ||
| 520 | |a BACKGROUND AND AIMS: For patients with congenitally corrected transposition of the great arteries (ccTGA), factors associated with progression to end-stage congestive heart failure (CHF) remain largely unclear | ||
| 520 | |a METHODS: This multicentre, retrospective cohort study included adults with ccTGA seen at a congenital heart disease centre. Clinical data from initial and most recent visits were obtained. The composite primary outcome was mechanical circulatory support, heart transplantation, or death | ||
| 520 | |a RESULTS: From 558 patients (48% female, age at first visit 36 ± 14.2 years, median follow-up 8.7 years), the event rate of the primary outcome was 15.4 per 1000 person-years (11 mechanical circulatory support implantations, 12 transplantations, and 52 deaths). Patients experiencing the primary outcome were older and more likely to have a history of atrial arrhythmia. The primary outcome was highest in those with both moderate/severe right ventricular (RV) dysfunction and tricuspid regurgitation (n = 110, 31 events) and uncommon in those with mild/less RV dysfunction and tricuspid regurgitation (n = 181, 13 events, P < .001). Outcomes were not different based on anatomic complexity and history of tricuspid valve surgery or of subpulmonic obstruction. New CHF admission or ventricular arrhythmia was associated with the primary outcome. Individuals who underwent childhood surgery had more adverse outcomes than age- and sex-matched controls. Multivariable Cox regression analysis identified older age, prior CHF admission, and severe RV dysfunction as independent predictors for the primary outcome | ||
| 520 | |a CONCLUSIONS: Patients with ccTGA have variable deterioration to end-stage heart failure or death over time, commonly between their fifth and sixth decades. Predictors include arrhythmic and CHF events and severe RV dysfunction but not anatomy or need for tricuspid valve surgery | ||
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Adult congenital heart disease | |
| 650 | 4 | |a Congestive heart failure | |
| 650 | 4 | |a Heart transplantation | |
| 650 | 4 | |a Mechanical circulatory support | |
| 650 | 4 | |a Systemic right ventricle | |
| 650 | 4 | |a Transposition of the great arteries | |
| 700 | 1 | |a Opotowsky, Alexander R |e verfasserin |4 aut | |
| 700 | 1 | |a Burchill, Luke J |e verfasserin |4 aut | |
| 700 | 1 | |a Aboulhosn, Jamil |e verfasserin |4 aut | |
| 700 | 1 | |a Grewal, Jasmine |e verfasserin |4 aut | |
| 700 | 1 | |a Lubert, Adam M |e verfasserin |4 aut | |
| 700 | 1 | |a Antonova, Petra |e verfasserin |4 aut | |
| 700 | 1 | |a Shah, Sangeeta |e verfasserin |4 aut | |
| 700 | 1 | |a Cotts, Timothy |e verfasserin |4 aut | |
| 700 | 1 | |a John, Anitha S |e verfasserin |4 aut | |
| 700 | 1 | |a Kay, William Aaron |e verfasserin |4 aut | |
| 700 | 1 | |a DeZorzi, Christopher |e verfasserin |4 aut | |
| 700 | 1 | |a Magalski, Anthony |e verfasserin |4 aut | |
| 700 | 1 | |a Han, Frank |e verfasserin |4 aut | |
| 700 | 1 | |a Baker, David |e verfasserin |4 aut | |
| 700 | 1 | |a Kay, Joseph |e verfasserin |4 aut | |
| 700 | 1 | |a Yeung, Elizabeth |e verfasserin |4 aut | |
| 700 | 1 | |a Vonder Muhll, Isabelle |e verfasserin |4 aut | |
| 700 | 1 | |a Pylypchuk, Stephen |e verfasserin |4 aut | |
| 700 | 1 | |a Kuo, Marissa C |e verfasserin |4 aut | |
| 700 | 1 | |a Nicolarsen, Jeremy |e verfasserin |4 aut | |
| 700 | 1 | |a Sarubbi, Berardo |e verfasserin |4 aut | |
| 700 | 1 | |a Fusco, Flavia |e verfasserin |4 aut | |
| 700 | 1 | |a Jameson, Susan M |e verfasserin |4 aut | |
| 700 | 1 | |a Cramer, Jonathan |e verfasserin |4 aut | |
| 700 | 1 | |a Gupta, Tripti |e verfasserin |4 aut | |
| 700 | 1 | |a Gallego, Pastora |e verfasserin |4 aut | |
| 700 | 1 | |a O'Donnell, Clare |e verfasserin |4 aut | |
| 700 | 1 | |a Hannah, Jane |e verfasserin |4 aut | |
| 700 | 1 | |a Dellborg, Mikael |e verfasserin |4 aut | |
| 700 | 1 | |a Kauling, Robert M |e verfasserin |4 aut | |
| 700 | 1 | |a Ginde, Salil |e verfasserin |4 aut | |
| 700 | 1 | |a Krieger, Eric V |e verfasserin |4 aut | |
| 700 | 1 | |a Rodriguez, Fred |e verfasserin |4 aut | |
| 700 | 1 | |a Dehghani, Payam |e verfasserin |4 aut | |
| 700 | 1 | |a Kutty, Shelby |e verfasserin |4 aut | |
| 700 | 1 | |a Wong, Joshua |e verfasserin |4 aut | |
| 700 | 1 | |a Wilson, William M |e verfasserin |4 aut | |
| 700 | 1 | |a Rodriguez-Monserrate, Carla P |e verfasserin |4 aut | |
| 700 | 1 | |a Roos-Hesselink, Jolien |e verfasserin |4 aut | |
| 700 | 1 | |a Celermajer, David S |e verfasserin |4 aut | |
| 700 | 1 | |a Khairy, Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Broberg, Craig S |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European heart journal |d 1983 |g 44(2023), 34 vom: 07. Sept., Seite 3278-3291 |w (DE-627)NLM012617253 |x 1522-9645 |7 nnns |
| 773 | 1 | 8 | |g volume:44 |g year:2023 |g number:34 |g day:07 |g month:09 |g pages:3278-3291 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/eurheartj/ehad511 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 44 |j 2023 |e 34 |b 07 |c 09 |h 3278-3291 | ||